Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Nov 12 - Nov 17
Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children
Maintaining healthy lipid metabolism and vascular function*
The use of a miR-200b-3p inhibitor led to a significant decrease in GSH levels, an increase in MDA levels, and an elevation of ferrous ion contents
Nimodipine, a calcium channel blocker, is one of the few current standard therapies following SAH as it has shown efficacy in reducing neurologic deficits from DCI, an effect believed to be due to the prevention of CV, though evidence of this mechanism via angiography visualization has been variable [16]
Next-generation incretin-based therapies offer additional promise: Dual and triple agonists show enhanced efficacy compared with GLP-1 monotherapy
US$ 20.79
US$ 23.36
US$ 26.91
US$ 22.20
US$ 23.67
US$ 20.82
US$ 26.03
US$ 24.70
